Last €140.39 EUR
Change Today -1.28 / -0.90%
Volume 2.8K
AMG On Other Exchanges
Symbol
Exchange
Hong Kong
Mexico
NASDAQ GS
Sao Paulo
Frankfurt
As of 1:01 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for amgen inc (AMG)

Year over year, Amgen Inc. has seen little change in their bottom line (from $5.1B USD to $5.2B USD) despite revenues that grew from $18.2B USD to $19.3B USD. A key factor has been an increase in the percentage of sales devoted to the cost of goods sold from 18.39% to 21.83%.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Reclassified
Dec 31
2012
Reclassified
Dec 31
2013
Reclassified
Dec 31
2014
4 Year
Trend
Revenues15,295.016,639.018,192.019,327.0
Other Revenues287.0626.0484.0736.0
TOTAL REVENUES15,582.017,265.018,676.020,063.0
Cost of Goods Sold2,643.03,081.03,346.04,219.0
GROSS PROFIT12,939.014,184.015,330.015,844.0
Selling General & Admin Expenses, Total4,546.04,814.05,148.04,690.0
R&D Expenses3,167.03,380.04,083.04,248.0
Other Operating Expenses7.045.0--42.0
OTHER OPERATING EXPENSES, TOTAL7,720.08,239.09,231.08,980.0
OPERATING INCOME5,219.05,945.06,099.06,864.0
Interest Expense-610.0-1,053.0-1,022.0-1,071.0
Interest and Investment Income298.0273.0248.0706.0
NET INTEREST EXPENSE-312.0-780.0-774.0-365.0
Income (Loss) on Equity Investments47.0------
Currency Exchange Gains (Loss)-4.080.097.0-240.0
EBT, EXCLUDING UNUSUAL ITEMS4,950.05,245.05,422.06,259.0
Merger & Restructuring Charges-174.0-293.0-107.0-657.0
Gain (Loss) on Sale of Investments154.0132.075.0-1.0
Other Unusual Items, Total-780.0-75.0-125.0-16.0
Legal Settlements-780.0---12.0--
Other Unusual Items---56.0-113.030.0
EBT, INCLUDING UNUSUAL ITEMS4,150.05,009.05,265.05,585.0
Income Tax Expense467.0664.0184.0427.0
Earnings from Continuing Operations3,683.04,345.05,081.05,158.0
NET INCOME3,683.04,345.05,081.05,158.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS3,683.04,345.05,081.05,158.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS3,683.04,345.05,081.05,158.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMG:GR €140.39 EUR -1.28

AMG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $47.37 USD -0.24
AbbVie Inc $60.50 USD -0.02
Bristol-Myers Squibb Co $60.92 USD -0.54
Eli Lilly & Co $70.17 USD +0.14
Novo Nordisk A/S kr319.70 DKK +3.70
View Industry Companies
 

Industry Analysis

AMG

Industry Average

Valuation AMG Industry Range
Price/Earnings 23.5x
Price/Sales 6.0x
Price/Book 4.7x
Price/Cash Flow 23.2x
TEV/Sales 3.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMGEN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.